[MOS] CIMIT Forum Tuesday April 17, 2007: Lester Wolfe Workshop in Laser Biomedicine: Optical Methods in Breast Cancer
Zina Queen
zqueen at MIT.EDU
Fri Apr 13 08:19:36 EDT 2007
Please Join Us at the CIMIT Forum / Lester Wolfe Workshop...
Tuesday, April 17, 2007
4:00-6:00pm
REFRESHMENTS at 3:30pm
Location: Massachusetts General Hospital, Richard
B. Simches Research Center, Room 3110, 185
Cambridge St, Boston
Directions to MGH and Richard B. Simches Research
Center: <http://www.cimit.org/directions.html>
http://www.cimit.org/directions.html
Map of MGH Campus:
<http://www.cimit.org/documents/SimchesMap.pdf>
http://www.cimit.org/documents/SimchesMap.pdf
Note: You will need to check in with Security
upon entering the Simches Research Center. PHS
employees, please bring your identification
badges. All others will be provided temporary
badges.
Lester Wolfe Workshop in Laser Biomedicine: Optical Methods in Breast Cancer
Early diagnosis, management and therapy of breast
cancer are important problems, and there is
interesting science as well. Optical methods hold
much promise. The Workshop will begin with an
overview, to be followed by presentations of
optical methodologies in forefront areas.
Sponsored by the MIT G.R. Harrison Spectroscopy
Laboratory, Massachusetts General Hospital
Wellman Center for Photomedicine; Harvard-MIT
Division of Health Sciences and Technology and
Center for Integration of Medicine and Innovative
Technology (CIMIT). Click here to read about
Lester Wolfe:
<http://web.mit.edu/spectroscopy/events/wolfe.html>
http://web.mit.edu/spectroscopy/events/wolfe.html
Moderator: Michael Hamblin, PhD, Associate
Professor, Wellman Center for Photomedicine, MGH
Introduction and Clinical Overview
Barbara L. Smith, MD, PhD, Director, Breast
Program of the Cancer Center and Co-Director of
the Womens Cancers Program, Massachusetts
General Hospital; Assistant Professor of Surgery,
Harvard Medical School and MGH; Chief of Breast
Surgical Services, Gillette Centers for Womens
Cancers, Dana-Farber Cancer Institute
Shedding Light on Breast Cancer: Advances in
Optical Spectroscopy Diagnosis of Breast Cancer
Maryann Fitzmaurice, MD, PhD, Associate Professor
of Pathology and Oncology, Case Western Reserve
University
Despite recent clinical advances, there remain
challenges to early diagnosis and effective
therapy of breast cancer. Among these are
mammographic false positives (mammographically
suspect lesions that are benign on biopsy) and
operative false negatives (positive margins
missed at breast cancer surgery that necessitate
re-operation for complete resection). Optical
spectroscopy holds promise for both improving the
accuracy of breast cancer diagnosis and enabling
breast cancer diagnosis to be made in a less
invasive and more timely fashion. Recent work on
the optical spectroscopy of breast cancer will be
reviewed, and results presented for ex vivo
pre-clinical studies using a multi-modality
technique that combines diffuse reflectance,
fluorescence and Raman spectroscopy to provide
more robust spectroscopic breast cancer diagnosis.
Breast Imaging and Characterization with Diffuse Optics
Arjun Yodh, PhD, James M. Skinner Professor of
Science, Department of Physics & Astronomy,
University of Pennsylvania
This talk is oriented towards functional imaging
and spectroscopy of breast cancer. Professor
Arjun Yodh will focus on several recent studies,
summarize the tumor contrast results obtained in
a pilot clinical investigation employing diffuse
optical tomography (DOT), and discuss the next
generation instrument. He will present first
in-vivo fluorescence diffuse optical tomography
(FDOT) of breast cancer, describe the measurement
of tumor blood flow and oxygenation of breast
cancer during chemotherapy, and, if time permits,
present multi-modal measurements combining DOT
with positron emission tomography (PET).
Intra-operative Optical Biopsy of Breast Cancer
Stephen Boppart, MD, PhD, Director, Mills Breast
Cancer Institute, Carle Foundation Hospital;
Associate Professor, Electrical Engineering,
Bioengineering, and Medicine, University of
Illinois at Urbana-Champaign
Traditionally, the microscopic evaluation and
diagnosis of tissue biopsy specimens has occurred
remote from the point-of-care, since tissue
processing, sectioning, and staining must be
performed. Coherent optical imaging techniques
such as optical coherence tomography (OCT) enable
real-time intra-operative visualization of tissue
architecture at cellular resolution, with the
potential to perform volumetric microscopy and
computer-automated classification over large
regions. OCT has been used intraoperatively to
assess margin status of lumpectomy specimens, and
to assess lymph nodes for evidence of metastases.
Fiber-optic beam delivery within needle probes
facilitates guiding needle biopsies of breast
masses. These methods enable real-time,
point-of-care feedback during surgical procedures
and interventions in the treatment of breast
cancer.
Click here to learn more about the CIMIT Forum:
<file://www.cimit.org/forum/current.html>
www.cimit.org/forum/current.html
Note: There is no registration required to attend the weekly CIMIT Forum.
CIMIT (Center for Integration of Medicine and
Innovative Technology) is a catalyst for the
application of technology to healthcare. The
focus is to bring together scientists and
engineers working at the frontiers of high
technology with clinicians who are at the
forefront of medicine. The goal of the CIMIT
Forum is to promote the exchange of ideas and
information between diverse communities and to
provide an arena where interdisciplinary
discussion can lead to breakthroughs in
biomedical engineering and ultimately patient
care. Dialogue is an important part of opening
doors for education and collaboration. The
audience is a diverse group of practitioners and
researchers, including clinicians, engineers,
educators, scientists, administrators and
students. For more information about Tuesday's
Forum, visit
<file://www.cimit.forum/current.html>
www.cimit.forum/current.html or contact DeAnna
Grosbaum, dgrosbaum at partners.org, 617-726-0797.
The information transmitted in this electronic
communication is intended only for the person or
entity to whom it is addressed and may contain
confidential and/or privileged material. Any
review, retransmission, dissemination or other
use of or taking of any action in reliance upon
this information by persons or entities other
than the intended recipient is prohibited. If you
received this information in error, please
contact the Compliance HelpLine at 800-856-1983
and properly dispose of this information.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://mailman.mit.edu/pipermail/mos/attachments/20070413/59c1fc60/attachment.htm
More information about the MOS
mailing list